Royalty Pharma Plc Capital Reinvestment Ratio
Royalty Pharma Plc capital reinvestment ratio. Royalty Pharma Plc (RPRX) has a Capital Reinvestment Ratio of 0.00x as of September 2025, meaning it reinvests 0% of its operating cash flow ($702.62 Million) in capital expenditures ($1.11 Million). See RPRX cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Royalty Pharma Plc (2002–2023)
Capital reinvestment ratio of Royalty Pharma Plc from 2002 to 2023. This chart tracks Royalty Pharma Plc's Capital Reinvestment Ratio across 8 annual periods. See Royalty Pharma Plc (RPRX) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Royalty Pharma Plc Capital Reinvestment Ratio by Year (2002–2023)
Royalty Pharma Plc capital reinvestment ratio by year from 2002 to 2023. For the full cash flow conversion analysis, see Royalty Pharma Plc cash conversion from operations.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.71x | $2.99 Billion | $2.12 Billion | ▼ -25.6% |
| 2022 | 0.95x | $2.14 Billion | $2.04 Billion | ▲ +367160.5% |
| 2021 | 0.00x | $2.02 Billion | $523.00K | ▼ -100.0% |
| 2020 | 1.08x | $2.03 Billion | $2.20 Billion | ▲ +4.6% |
| 2019 | 1.03x | $1.67 Billion | $1.72 Billion | ▲ +519.7% |
| 2018 | 0.17x | $1.62 Billion | $269.59 Million | ▼ -89.7% |
| 2017 | 1.62x | $1.42 Billion | $2.29 Billion | ▲ +27735.6% |
| 2002 | 0.01x | $8.45 Million | $49.00K | — |